Publication | Closed Access

Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide

Hematological MalignancyRadiation OncologyChildhood Myeloid MalignanciesTransplantationMarrow TransplantationBone Marrow FailureStem Cell TransplantationHematologyImmunologyHigh-dose ThiotepaImmunotherapyMedicineCell TransplantationHealth Sciences